EpiPen ShortageJune 7th, 2018 | Network News•News
Navigating the EpiPen Shortage: The FDA has announced a manufacturing shortage of Mylan’s EpiPen and its authorized generic, epinephrine auto-injector. The shortage is expected to be “short-term” but an estimated resupply date has not been provided. Generic Adrenaclick is also in shortage, however details on the expected duration are not available. Despite ongoing shortages, patients should be able to obtain epinephrine auto-injectors, but may need to contact more than one pharmacy to find the product in stock.
Suggestions before switching to a new device:
1. Advise patients to request a refill from their pharmacy before needing it. Some pharmacies have reported several-week waiting lists to obtain the Mylan products.
2. Ensure patients check several pharmacies as supply will vary.
• Patients can call Mylan customer service (800-796-9526) for assistance locating stock at local pharmacies.
3. If a patient must switch to another brand, ensure they are educated on how to use the new device. The medication is the same, however the delivery system and method for injecting differ by brand.
We will continue to monitor the shortage and will update the network as more information becomes available. If you would like to check the status of this or other shortages, you can use the FDA website or the ASHP website and search “epinephrine.”